Rhinitis 2020: a practice parameter update
MS Dykewicz, DV Wallace, DJ Amrol… - Journal of Allergy and …, 2020 - Elsevier
This comprehensive practice parameter for allergic rhinitis (AR) and nonallergic rhinitis
(NAR) provides updated guidance on diagnosis, assessment, selection of monotherapy and …
(NAR) provides updated guidance on diagnosis, assessment, selection of monotherapy and …
Corticosteroids in ophthalmology: Drug delivery innovations, pharmacology, clinical applications, and future perspectives
SA Gaballa, UB Kompella, O Elgarhy… - Drug Delivery and …, 2021 - Springer
Corticosteroids remain the mainstay of the treatment for various ocular conditions affecting
the ocular surface, anterior and posterior segments of the eye due to their anti-inflammatory …
the ocular surface, anterior and posterior segments of the eye due to their anti-inflammatory …
[HTML][HTML] Steroid-induced glaucoma: an avoidable irreversible blindness
Steroid-induced Glaucoma: An Avoidable Irreversible Blindness - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …
Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management
G Roberti, F Oddone, L Agnifili, A Katsanos… - Survey of …, 2020 - Elsevier
Glucocorticoids are a class of anti-inflammatory drugs commonly used to treat various ocular
and systemic conditions. Although the role of glucocorticoids in the treatment of numerous …
and systemic conditions. Although the role of glucocorticoids in the treatment of numerous …
[图书][B] Shields textbook of glaucoma
RR Allingham, KF Damji, SF Freedman, SE Moroi… - 2012 - books.google.com
Thoroughly updated, and now in full color, Shields' Textbook of Glaucoma, Sixth Edition is a
clinically focused and practical textbook for general ophthalmologists treating patients with …
clinically focused and practical textbook for general ophthalmologists treating patients with …
Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis
BJ Lipworth - Archives of internal medicine, 1999 - jamanetwork.com
Objective To appraise the data on systemic adverse effects of inhaled corticosteroids.
Methods A computerized database search from January 1, 1966, through July 31, 1998 …
Methods A computerized database search from January 1, 1966, through July 31, 1998 …
Hydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet milling
Recently, drug nanosuspensions have shown a potential for ophthalmic delivery. In this
study, a hydrocortisone (HC) nanosuspension (NS) was developed using microfluidic …
study, a hydrocortisone (HC) nanosuspension (NS) was developed using microfluidic …
Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma
E Garbe, J LeLorier, JF Boivin, S Suissa - Jama, 1997 - jamanetwork.com
Objective.—To determine whether the use of inhaled and nasal glucocorticoids is
associated with an increased risk of ocular hypertension or open-angle glaucoma. Design …
associated with an increased risk of ocular hypertension or open-angle glaucoma. Design …
Corticosteroids and glaucoma risk
RC Tripathi, SK Parapuram, BJ Tripathi, Y Zhong… - Drugs & aging, 1999 - Springer
Corticosteroids (glucocorticoids), used frequently as potent anti-inflammatory agents,
increase the risk of glaucoma by raising the intraocular pressure (IOP) when administered …
increase the risk of glaucoma by raising the intraocular pressure (IOP) when administered …
Clinical characteristics and current treatment of glaucoma
LP Cohen, LR Pasquale - Cold Spring …, 2014 - perspectivesinmedicine.cshlp.org
Glaucoma is a neurodegenerative disorder in which degenerating retinal ganglion cells
(RGC) produce significant visual disability. Clinically, glaucoma refers to an array of …
(RGC) produce significant visual disability. Clinically, glaucoma refers to an array of …